研究

Jones DR, Opitz I, Harpole D, Yanagawa J, Lim E, Tsutani Y, Tan DSW, Dacic S, Ganti AK, Bodla S, Batig A, Lyfar P, Forcina A, Felip E.

TROPION-Lung12: A phase 3 study of adjuvant datopotamab deruxtecan and rilvegostomig in ctDNA-positive or high-risk pathology stage I non-small cell lung cancer.

Tsuchiya A, Utsunomiya H, Kamigaichi A, Tsutani Y, Hamada A, Takeuchi M, Hyodo Y, Mogami A, Takahari K, Ueda Y, Miyata Y, Okada M, Nakano Y.

Determinants and Mechanisms of Postoperative Effort Intolerance in Suspected Lung Cancer　- An Exercise-Stress Echocardiography Study.

Zhang Y, Zhang Q, Hao Y, Luo J, Piao Y, Wang W, Song Z, Li Z, Brcic L, Liu A, Yu J, Tsutani Y, et al.

International guidelines on the diagnosis and treatment of NUT carcinoma.

Hayasaka K, Shimokawa M, Haratake N, Notsuda H, Katsumata S, Hamada A, Nomura K, Fujino K, Yoshikawa M, Suzawa K, Shien K, Suda K, Ohara S, Fukuda S, Kinoshita I, Takamori S, Muto S, Takanashi Y, Mizuno K, Hayakawa T, Sekihara K, Toda M, Matsuo S, Takegahara K, Hashimoto M, Nakahashi K, Endo M, Ozawa H, Fujikawa R, Tomioka Y, Namba K, Matsubara T, Suzuki J, Watanabe H, Takada K, Hoshino H, Kaiho T, Toyoda T, Shiono S, Soh J, Ohde Y, Okada Y.

Survival outcomes of patients with uncommon EGFR mutations in surgically resected lung adenocarcinoma: A multi-institutional real-world database study (CReGYT-01 EGFR study)

Fukami T, Tsutani Y.

Reply: Understanding Deauville score in stage I non-small cell lung cancer.